Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEVLABS, Inc. is a research and development company specializing in public health solutions, particularly in the field of infectious disease prevention and vector control. The company develops innovative technologies to combat arthropod-borne diseases like malaria and dengue, with a focus on eco-friendly and affordable products. Their flagship technologies include the ProVector® delivery system and Entobac® biocide formulations, which are designed to target disease-carrying insects efficiently. MEVLABS also provides expert consulting, diagnostic testing, and software for infectious disease risk assessment. As a disabled veteran-owned small business, they collaborate with government agencies and international research organizations to implement health interventions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEVLABS.